Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens

Medicine (United States)

Volumn 96, Issue 39, 2017, Pages

  Zhao, Long ^a   Huang, Shanshan ^a   Liu, Jinjun ^a   Zhao, Juan ^a   Li, Qiang ^a   Wang, Huo Qiang ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

EGFR; KRAS; primary pulmonary enteric adenocarcinoma; pulmonary carcinosarcoma; pulmonary invasive adenocarcinoma; villin

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR; KRISTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG PROTEIN; NAPSIN A; PROTEIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG; VILLIN; ACTIN BINDING PROTEIN; BIOLOGICAL MARKER; EGFR PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; PROTEIN P21; VILLIN1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BACKACHE; CANCER INCIDENCE; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; COUGHING; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; GENE MUTATION; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG LESION; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT CARE; PLEURA EFFUSION; PLEURA LOBULATION; PLEURAL INDENTATION; PRIMARY PULMONARY ENTERIC ADENOCARCINOMA; PRIMARY PULMONARY INVASIVE ADENOCARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEGMENTECTOMY; SEX DIFFERENTIATION; SOLID MALIGNANT NEOPLASM; THORAX PAIN; THORAX RADIOGRAPHY; THORAX SURGERY; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY; ADENOCARCINOMA; COLONIC NEOPLASMS; DIAGNOSTIC IMAGING; GENETICS; LUNG; LUNG NEOPLASMS; NEOPLASM METASTASIS; PATHOLOGY; PROCEDURES; STATISTICS; TUMOR INVASION;

ADENOCARCINOMA; AGED; BIOMARKERS; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTOR, EPIDERMAL GROWTH FACTOR; STATISTICS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85030753951     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000008153     Document Type: Article

References (40)

1. Chen W, Zheng R, Zeng H, et al. The incidence and mortality of major cancers in China, 2012. Chin J Cancer 2016;35:73.
2. Fajersztajn L, Veras M, Barrozo LV, et al. Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer 2013;13:674-8.
3. Chen ZM, Peto R, Iona A, et al. Emerging tobacco-related cancer risks in China: a nationwide, prospective study of 0.5 million adults. Cancer 2015;121(suppl 17):3097-106.
4. Kim C, Gao YT, Xiang YB, et al. Home kitchen ventilation, cooking fuels, and lung cancer risk in a prospective cohort of never smoking women in Shanghai, China. Int J Cancer 2015;136:632-8.
5. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2013. Bethesda, MD: National Cancer Institute; 2016. Available from: http://seer.cancer.gov/csr/1975-2013/.
6. Tsao MS, Fraser RS. Primary pulmonary adenocarcinoma with enteric differentiation. Cancer 1991;68:1754-7.
7. Travis WD, Brambilla E, NoguchiM, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-85.
8. Travis WD, Brambilla E, Burke AP, et al. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th edIARC Press, Lyon:2015.
9. Weidner N. Pulmonary adenocarcinoma with intestinal-type differentiation. Ultrastruct Pathol 1992;16:7-10.
10. Inamura K, Satoh Y, Okumura S, et al. Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg Pathol 2005;29:660-5.
11. Yousem SA. Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study. Mod Pathol 2005;18:816-21.
12. Satoh Y, Hoshi R, TsuzukuM, et al. Cytology of pulmonary cytology of pulmonary adenocarcinomas showing enteric differentiation. Acta Cytol 2006;50:250-6.
13. Maeda R, Isowa N, Onuma H, et al. Pulmonary intestinal-type adenocarcinoma. Interact Cardiovasc Thorac Surg 2008;7:349-51.
14. Li HC, Schmidt L, Greenson JK, et al. Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature. Am J Clin Pathol 2009;131:129-33.
15. Hatanaka K, Tsuta K, Watanabe K, et al. Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: a report of the second case negative for cytokeratin 7. Pathol Res Pract 2011;207:188-91.
16. Lin D, Zhao Y, LiH, et al. Pulmonary enteric adenocarcinoma with villin brush border immunoreactivity: a case report and literature review. J Thorac Dis 2013;5:E17-E20.
17. Qureshi A, Furrukh M. Enteric adenocarcinoma lung: a rare presentation in an Omani woman. BMJ Case Rep 2013;2013:bcr2012007667.
18. Wang CX, Liu B,Wang YF, et al. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases. Int J Clin Exp Pathol 2014;7:1266-74.
19. Stojsic J,KonticM,SuboticD, et al. Intestinal type of lung adenocarcinoma in younger adults. Case Rep Pulmonol 2014;2014:282196.
20. László T, Lacza A, Tóth D, et al. Pulmonary enteric adenocarcinoma indistinguishable morphologically and immunohistologically from metastatic colorectal carcinoma. Histopathology 2014;65:283-7.
21. Garajová I, Funel N, Fiorentino M, et al. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy. Clin Epigenetics 2015;7:129.
22. Handa Y, Kai Y, Ikeda T, et al. Pulmonary enteric adenocarcinoma. Gen Thorac Cardiovasc Surg 2016;64:749-51.
23. Metro G, Valtorta E, Siggillino A, et al. Enteric-type adenocarcinoma of enteric enteric the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report. Ecancermedicalscience 2015;9:559.
24. Lin LI, Xu CW, Zhang BO, et al. Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: a case report and review of the literature. Exp TherMed 2016;11:201-7.
25. El Hammoumi MM, El Ochi R, Kabiriel H. Primary lung adenocarcinoma with enteric morphology associated with primary colon adenocarcinoma. Arch Bronconeumol 2016;52:221.
26. Nottegar A, Tabbò F, Luchini C, et al. Pulmonary adenocarcinoma with enteric differentiation: immunohistochemistry and molecular morphology. Appl Immunohistochem Mol Morphol 2016;DOI: 10.1097/ PAI.0000000000000440. [Epub ahead of print].
27. Dolscheid-Pommerich RC, Manekeller S, Walgenbach-Brünagel G, et al. Clinical performance of CEA, CA19-9, CA15-3, CA125 and AFP in gastrointestinal cancer using LOCITM-based assays. Anticancer Res 2017;37:353-9.
28. Stojkovic Lalosevic M, Stankovic S, Stojkovic M, et al. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients? Hell J Nucl Med 2017;20:41-5.
29. Yoshino T, Obermannová R, Bodoky G, et al. Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-linemetastatic colorectal carcinoma phase III trial. Eur J Cancer 2017;78:61-9.
30. Liu Y, Balagurunathan Y, Atwater T, et al. Radiological image traits predictive of cancer status in pulmonary nodules. Clin Cancer Res 2017;23:1442-9.
31. McWilliamsA,TammemagiMC,MayoJR.Probabilityof cancer inpulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910-9.
32. Bacchi CE, Gown AM. Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue. Lab Invest 1991;64: 418-24.
33. NambuY, IannettoniMD,OrringerMB, et al.Unique expression patterns and alterations in the intestinal protein villin in primary and metastaticpulmonary adenocarcinomas. Mol Carcinog 1998;23:234-42.
34. Tan J, Sidhu G, Greco MA, et al. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructuralevidence of microvilli with rootlets. Hum Pathol 1998;29:390-6.
35. Dong YJ, Cai YR, Zhou LJ, et al. Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification. Oncol Lett 2016;11:2552-8.
36. Yoshizawa A, Sumiyoshi S, Sonobe M, et al. Validation of the IASLC/ ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013;8:52-61.
37. Lee B, Lee T, Lee SH, et al. Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers. Oncotarget 2016;7:23874-84.
38. Ambrogio C, Gómez-López G, Falcone M, et al. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma. Nat Med 2016;22:270-7.
39. Manchado E, Weissmueller S, Morris JP IV, et al.Acombinatorial strategy for treating KRAS-mutant lung cancer. Nature 2016;534:647-51.
40. de Lima Lopes GJr, Segel JE, Tan DS, et al. Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung. Cancer 2012;118:1032-9.